GT199800053A - PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF THE N-PIPERIDINE-5- (4-CHLOROPHENYL) -1- (2,4-DICHLOROPHENYL) -4-METHYLPIRAZOLE-3-CARBOXAMIDE, OF ITS SALES AND DESUSSOLVATES. - Google Patents

PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF THE N-PIPERIDINE-5- (4-CHLOROPHENYL) -1- (2,4-DICHLOROPHENYL) -4-METHYLPIRAZOLE-3-CARBOXAMIDE, OF ITS SALES AND DESUSSOLVATES.

Info

Publication number
GT199800053A
GT199800053A GT199800053A GT199800053A GT199800053A GT 199800053 A GT199800053 A GT 199800053A GT 199800053 A GT199800053 A GT 199800053A GT 199800053 A GT199800053 A GT 199800053A GT 199800053 A GT199800053 A GT 199800053A
Authority
GT
Guatemala
Prior art keywords
administration
methylpirazole
desussolvates
dichlorophenyl
carboxamide
Prior art date
Application number
GT199800053A
Other languages
Spanish (es)
Inventor
Bernard Abramovici
Christian Condamine
Jean-Claude Gromenil
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to GT199800053A priority Critical patent/GT199800053A/en
Publication of GT199800053A publication Critical patent/GT199800053A/en

Links

Abstract

COMPOSICION FARMACEUTICA PARA LA ADMINISTRACION ORAL DEL NPIPERIDINO5(4CLOROFENIL)1(2,4DICLOROFENIL)4METILPIRAZOLO3CARBOXAMIDA; O DE UNA DE SUS SALES FARMACEUTICAMENTE ACEPTABLES O DE UNO DE SUS SOLVATOS (EN ADELANTE PRINCIPIO ACTIVO), QUE COMPRENDE: 0.05% A 0.5% EN PESO DE UN ALQUILSULFATO DE SODIO, 2.5% A 10% EN PESO DE AGENTE DE DESAGREGACION, Y EXCIPIENTES FARMACEUTICOS.PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF NPIPERIDINO5 (4CLOROFENIL) 1 (2,4DICLOROFENIL) 4METILPIRAZOLO3CARBOXAMIDA; OR OF ONE OF ITS PHARMACEUTICALLY ACCEPTABLE SALTS OR OF ONE OF ITS SOLVATES (IN ADVANCE ACTIVE SUBSTANCE), WHICH INCLUDES: 0.05% TO 0.5% BY WEIGHT OF A SODIUM ALKYL SULPHATE, 2.5% TO 10% BY WEIGHT OF DISAGGREGATION AGENT, AND PHARMACEUTICAL EXCIPIENTS.

GT199800053A 1998-03-26 1998-03-26 PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF THE N-PIPERIDINE-5- (4-CHLOROPHENYL) -1- (2,4-DICHLOROPHENYL) -4-METHYLPIRAZOLE-3-CARBOXAMIDE, OF ITS SALES AND DESUSSOLVATES. GT199800053A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GT199800053A GT199800053A (en) 1998-03-26 1998-03-26 PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF THE N-PIPERIDINE-5- (4-CHLOROPHENYL) -1- (2,4-DICHLOROPHENYL) -4-METHYLPIRAZOLE-3-CARBOXAMIDE, OF ITS SALES AND DESUSSOLVATES.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GT199800053A GT199800053A (en) 1998-03-26 1998-03-26 PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF THE N-PIPERIDINE-5- (4-CHLOROPHENYL) -1- (2,4-DICHLOROPHENYL) -4-METHYLPIRAZOLE-3-CARBOXAMIDE, OF ITS SALES AND DESUSSOLVATES.

Publications (1)

Publication Number Publication Date
GT199800053A true GT199800053A (en) 1999-09-17

Family

ID=47043828

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199800053A GT199800053A (en) 1998-03-26 1998-03-26 PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF THE N-PIPERIDINE-5- (4-CHLOROPHENYL) -1- (2,4-DICHLOROPHENYL) -4-METHYLPIRAZOLE-3-CARBOXAMIDE, OF ITS SALES AND DESUSSOLVATES.

Country Status (1)

Country Link
GT (1) GT199800053A (en)

Similar Documents

Publication Publication Date Title
CO4950527A1 (en) PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION OF N- PIPERIDINE-5- (4-CHLOROPHENYL) -1- (2,4-DICHLOROPHENYL) -4- METHYLPIRAZOLE-3-CARBOXAMIDE, ITS SALTS AND ITS SOLVATES
PA8453201A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING VORICONAZOLE
ES2159591T3 (en) COMPOSITION OF CONTROLLED RELEASE.
AR054782A2 (en) PHARMACEUTICAL COMPOSITIONS AND TABLETS CONTAINING IRBESARTAN IN COMBINATION WITH A DIURETIC
AR018862A1 (en) PHARMACEUTICAL FORMULATION OF PROLONGED RELEASE, IMPROVED FOR THE ORAL ADMINISTRATION OF NEFAZODONA OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME; ORAL DOSAGE FORM THAT UNDERSTANDS AND USE OF SUCH FORMULATION TO PREPARE THE SUCH DOSAGE FORM
DE60142891D1 (en) AZETIDINE DERIVATIVES PHARMACEUTICAL COMPOSITIONS, THE AZETIDINE DERIVATIVES AND THEIR PREPARATION
ATE260646T1 (en) RAPID DISSOLVING ORAL DOSAGE FORM
CO5190672A1 (en) COMPOSITION FOR ORAL DOSAGE, INSTANT DISSOLUTION
MX9300664A (en) PHARMACEUTICAL DOSAGE FORMS CONTAINING PROLONGED RELEASE OF ACTIVE INGREDIENT.
KR950007841A (en) Sustained-release drug formulations containing tramadol salts
PA8548701A1 (en) AZAINDOLS
IT1271495B (en) PHARMACEUTICAL COMPOSITION CONTAINING 3-2 (DIMETHYLAMINE) ETHYL-N-METHYL-1H-INDOL-5-METHANE SULPHONAMIDE, RELATIVE PROCEDURE FOR PREPARATION AND USE OF THE SAME IN TREATMENT OF MAMMALS
BR0015605A (en) Composition and use
AR018197A1 (en) PIPERIDINE COMPOUNDS, A PROCEDURE FOR THE PREPARATION, A COMPOSITION AND USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT
AR033688A1 (en) RECONSTITUABLE PARENTERAL COMPOSITION
SE0102843D0 (en) Stabilized oral pharmaceutical composition containing lodide and lodate and method
CA2136404A1 (en) Mucoadhesive, therapeutic or hygienic solid composition for application on oral or nasal mucosa
DK1104289T3 (en) New oral formulations for 5-HT 4 agonists or antagonists
AR046036A1 (en) RISEDRONATE COMPOSITIONS AND METHODS FOR USE
EA200001010A1 (en) APPLICATION OF DEXMEDETOMIDINE FOR SEDATIVE IMPACT IN THE DEPARTMENT OF INTENSIVE THERAPY
AR005860A1 (en) AROMATIC HETERO-CYCLE COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM, AND THEIR USE.
PT92647A (en) 5-CHLORO-2 - [((3,4-DIMETHOXY-2-PYRIDINYL) -METHYL) SULFINYL) -1H-BENZIMIDAZOLE AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING IT
ES2175663T3 (en) SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING MILTEPHOSINE FOR ORAL ADMINISTRATION IN THE TREATMENT OF LESHMANIASIS.
UY27539A1 (en) PHARMACEUTICAL FORMULATION
CO5700738A2 (en) CELECOXIB PROFARMACO